{"title":"Immuno-electron microscopy localizes Caenorhabditis elegans vitellogenins along the classic exocytosis route","authors":"Chao Zhai, Nan Zhang, Xixia Li, Xue-Ke Tan, Fei Sun, Meng-Qiu Dong","doi":"10.1093/lifemeta/loae025","DOIUrl":"https://doi.org/10.1093/lifemeta/loae025","url":null,"abstract":"\u0000 Vitellogenins (VITs) are the most abundant proteins in adult hermaphrodite Caenorhabditis elegans. VITs are synthesized in the intestine, secreted to the pseudocoelom, matured into yolk proteins, and finally deposited in oocytes as nutrients for progeny developme nt. How VITs are secreted out of the intestine remains unclear. Using immuno-electron microscopy (immuno-EM), we localize intestinal VITs along an exocytic pathway consisting of the rough endoplasmic reticulum (ER), the Golgi, and the lipid bilayer-bounded VIT vesicles (VVs). This suggests that the classic exocytotic pathway mediates the secretion of VITs from the intestine to the pseudocoelom. We also show that pseudocoelomic yolk patches (PYPs) are membrane-less and amorphous. The different VITs/yolk proteins are packed as a mixture into the above structures. The size of VVs can vary with the VIT levels and the age of the worm. On adult day 2 (AD 2), intestinal VVs (~200 nm in diameter) are smaller than gonadal yolk organelles (YOs, ~500 nm in diameter). VVs, PYPs, and YOs share a uniform medium electron density by conventional EM. The morphological profiles documented in this study serve as a reference for future studies of VITs/yolk proteins.","PeriodicalId":74074,"journal":{"name":"Life metabolism","volume":"3 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141346708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Life metabolismPub Date : 2024-06-13DOI: 10.1093/lifemeta/loae023
H. Demagny, A. Perino, Kristina Schoonjans
{"title":"Protecting liver health with microbial-derived succinylated bile acids","authors":"H. Demagny, A. Perino, Kristina Schoonjans","doi":"10.1093/lifemeta/loae023","DOIUrl":"https://doi.org/10.1093/lifemeta/loae023","url":null,"abstract":"","PeriodicalId":74074,"journal":{"name":"Life metabolism","volume":"39 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141347959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Life metabolismPub Date : 2024-06-07DOI: 10.1093/lifemeta/loae024
Peter U Amadi, Da-wei Zhang
{"title":"Cholesin, a new hormone bridges intestinal cholesterol absorption and hepatic synthesis","authors":"Peter U Amadi, Da-wei Zhang","doi":"10.1093/lifemeta/loae024","DOIUrl":"https://doi.org/10.1093/lifemeta/loae024","url":null,"abstract":"","PeriodicalId":74074,"journal":{"name":"Life metabolism","volume":" 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141372758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Life metabolismPub Date : 2024-06-01Epub Date: 2023-12-27DOI: 10.1093/lifemeta/load051
Anna S Monzel, Michael Levin, Martin Picard
{"title":"The energetics of cellular life transitions.","authors":"Anna S Monzel, Michael Levin, Martin Picard","doi":"10.1093/lifemeta/load051","DOIUrl":"10.1093/lifemeta/load051","url":null,"abstract":"<p><p>Major life transitions are always difficult because change costs energy. Recent findings have demonstrated how mitochondrial oxidative phosphorylation (OxPhos) defects increase the energetic cost of living, and that excessive integrated stress response (ISR) signaling may prevent cellular identity transitions during development. In this perspective, we discuss general bioenergetic principles of life transitions and the costly molecular processes involved in reprograming the cellular hardware/software as cells shift identity. The energetic cost of cellular differentiation has not been directly quantified, representing a gap in knowledge. We propose that the ISR is an energetic checkpoint evolved to i) prevent OxPhos-deficient cells from engaging in excessively costly transitions, and ii) allow ISR-positive cells to recruit systemic energetic resources by signaling via the brain.</p>","PeriodicalId":74074,"journal":{"name":"Life metabolism","volume":"3 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10984639/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140857419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Spatial multi-omics characterizes GPR35-relevant lipid metabolism signatures across liver zonation in MASLD.","authors":"Wuxiyar Otkur, Yiran Zhang, Yirong Li, Wenjun Bao, Tingze Feng, Bo Wu, Yaolu Ma, Jing Shi, Li Wang, Shaojun Pei, Wen Wang, Jixia Wang, Yaopeng Zhao, Yanfang Liu, Xiuling Li, Tian Xia, Fangjun Wang, Di Chen, Xinmiao Liang, Hai-Long Piao","doi":"10.1093/lifemeta/loae021","DOIUrl":"10.1093/lifemeta/loae021","url":null,"abstract":"<p><p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a metabolic disease that can progress to metabolic dysfunction-associated steatohepatitis (MASH), cirrhosis, and cancer. The zonal distribution of biomolecules in the liver is implicated in mediating the disease progression. Recently, G-protein-coupled receptor 35 (GPR35) has been highlighted to play a role in MASLD, but the precise mechanism is not fully understood, particularly, in a liver-zonal manner. Here, we aimed to identify spatially distributed specific genes and metabolites in different liver zonation that are regulated by GPR35 in MASLD, by combining lipid metabolomics, spatial transcriptomics (ST), and spatial metabolomics (SM). We found that GPR35 influenced lipid accumulation, inflammatory and metabolism-related factors in specific regions, notably affecting the anti-inflammation factor ELF4 (E74 like E-twenty six (ETS) transcription factor 4), lipid homeostasis key factor CIDEA (cell death-inducing DNA fragmentation factor alpha (DFFA)-like effector A), and the injury response-related genes <i>SAA1/2/3</i> (serum amyloid A1/2/3), thereby impacting MASLD progression. Furthermore, SM elucidated specific metabolite distributions across different liver regions, such as C10H11N4O7P (3',5'-cyclic inosine monophosphate (3',5'-IMP)) for the central vein, and this metabolite significantly decreased in the liver zones of <i>GPR35</i>-deficient mice during MASLD progression. Taken together, GPR35 regulates hepatocyte damage repair, controls inflammation, and prevents MASLD progression by influencing phospholipid homeostasis and gene expression in a zonal manner.</p>","PeriodicalId":74074,"journal":{"name":"Life metabolism","volume":"3 6","pages":"loae021"},"PeriodicalIF":0.0,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11748505/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143054440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Life metabolismPub Date : 2024-05-24eCollection Date: 2024-08-01DOI: 10.1093/lifemeta/loae019
Callen C Goldsmith, Garron T Dodd
{"title":"TET2: the fat controller of leptin.","authors":"Callen C Goldsmith, Garron T Dodd","doi":"10.1093/lifemeta/loae019","DOIUrl":"10.1093/lifemeta/loae019","url":null,"abstract":"","PeriodicalId":74074,"journal":{"name":"Life metabolism","volume":"3 4","pages":"loae019"},"PeriodicalIF":0.0,"publicationDate":"2024-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11749346/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143054446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Fatty acid oxidation-induced HIF-1α activation facilitates hepatic urate synthesis through upregulating NT5C2 and XDH","authors":"Ningning Liang, Xuan Yuan, Lili Zhang, Xia Shen, Shanshan Zhong, Luxiao Li, Rui Li, Xiaodong Xu, Xin Chen, Chunzhao Yin, Shuyuan Guo, Jing Ge, Mingjiang Zhu, Yongzhen Tao, Shiting Chen, Yongbing Qian, Nicola Dalbeth, Tony R. Merriman, R. Terkeltaub, Changgui Li, Qiang Xia, Huiyong Yin","doi":"10.1093/lifemeta/loae018","DOIUrl":"https://doi.org/10.1093/lifemeta/loae018","url":null,"abstract":"\u0000 Dyslipidemia affects approximately half of all people with gout, and prior Mendelian randomization analysis suggested a causal role for elevated triglycerides in hyperuricemia (HU), but the underlying mechanisms remain elusive. We hypothesize that dyslipidemia promotes hepatic urate biosynthesis in HU and gout and fatty acid (FA) oxidation (FAO) drives this process. Here we developed a targeted metabolomics to quantify major metabolites in purine metabolic pathway in the sera of a human cohort with HU, gout, and normaluricemic controls. We found that the levels of major purine metabolites and multiple FAs were significantly elevated in HU and gout, compared to normouricemic controls, whereas hypoxathine showed opposite trend. Furthermore, the levels of multiple serum FAs were positively correlated with urate, xanthine, and inosine but negatively with hypoxanthine, which was also observed in a murine model of high-fat diet-induced HU. Using a stable isotope labeled metabolic flux assay, we discovered that exogenous hypoxanthine plays a key role in urate synthesis. Moreover, FAO-induced hypoxia-inducible factor 1 alpha (HIF-1α) activation upregulated 5’-nucleotidase II (NT5C2) and xanthine dehydrogenase (XDH) levels to facilitate hypoxanthine uptake from blood to liver and activation of urate biosynthesis. Our findings was further supported by data in human hepatocytes and 50 paired serum and liver tissues from liver transplant donors.Together, this study uncovers a mechanism by which FAO promotes hepatic urate synthesis by activating HIF-1α-NT5C2/XDH pathways, directly linking lipid metabolism to HU.","PeriodicalId":74074,"journal":{"name":"Life metabolism","volume":"2 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140963036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Hypoxia makes EZH2 inhibitor not easy—advances of crosstalk between HIF and EZH2","authors":"Zhanya Huang, Yuanjun Tang, Jianlin Zhang, Jiaqi Huang, Rui Cheng, Yunyun Guo, Celina G Kleer, Yuqing Wang, Lixiang Xue","doi":"10.1093/lifemeta/loae017","DOIUrl":"https://doi.org/10.1093/lifemeta/loae017","url":null,"abstract":"\u0000 Histone methylation plays a crucial role in tumorigenesis. Enhancer of zeste homolog 2 (EZH2) is a histone methyltransferase that regulates chromatin structure and gene expression. EZH2 inhibitors (EZH2is) have been shown to be effective in treating hematologic malignancies, while their effectiveness in solid tumors remains limited. One of the major challenges in the treatment of solid tumors is their hypoxic tumor microenvironment. Hypoxia-inducible factor 1-alpha (HIF-1α) is a key hypoxia responder that interacts with EZH2 to promote tumor progression. Here we discuss the implications of the relationship between EZH2 and hypoxia for expanding the application of EZH2is in solid tumors.","PeriodicalId":74074,"journal":{"name":"Life metabolism","volume":"50 18","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141010100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}